drugset / Trial / NCT02109315

Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.

NCT02109315

Phase 1 Withdrawn Anna Cruceta
RandomizedParallel-groupOpen-labelTreatment

Summary

To investigate the effect of liraglutide on vascular injury induced hypoglycemia in patients with type 1 diabetes mellitus. The vascular damage is evaluated at investigating the changes of endothelial function

Timeline

Start
2014-05
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Liraglutide Peptide 0.6 mg Intravenous
Subject Vitamine C Unknown 30 mg Intravenous